Validant

Sector: Healthcare,Pharma

Provides specialist consulting services focusing on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors

Business Overview

  • Founded in 2005, Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors
  • Headquartered in San Francisco, the company operates globally with offices in Europe and North America
  • Validant has established longstanding relationships with many of the market leaders in the pharmaceutical, medical device and biotechnology sectors. In 2018, the company had a strong blue-chip customer base of over 100 companies, including Johnson & Johnson, KPMG, Pfizer and GlaxoSmithKline
  • The company provides consulting services across three key areas:
    • Routine quality assurance and compliance assistance, such as ensuring that its customers’ processes adhere to quality standards set by regulator
    • Strategic projects to help its customers to remain at the forefront of quality and compliance challenges, for example, by understanding regulatory requirements associated with new product development
    • Projects to help customers respond to regulatory enforcement actions

Investment Thesis

  • Large and growing global addressable market driven by increased regulatory requirements on pharmaceutical and medical technology companies
  • Strategic growth opportunities in Europe through execution of buy-and-build strategy
  • Longstanding and diversified blue chip customer base with over 100 customers
  • High barriers to entry associated with the majority of Validant’s customer base limiting the number of companies used for advising on regulatory matters
  • Experienced sponsor with a strong track record and specialism for investments in the healthcare and pharmaceuticals sector